ArticleDiscover oncology2025

Metabolic reprogramming and immune microenvironment profiling in clear cell renal cell carcinoma: implications for prognosis, targeted therapy, and drug resistance.

Xiao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.